Although it has been reported that deficiency of TLR4 is associated with reduced atherosclerosis in mice and attenuated pro-inflammatory state in diabetic mice, it remains unknown whether treatment with TLR4 antagonists reduces atherosclerosis in non-diabetic and diabetic mice [45]. This evidence concerns the gene TLR4 and atherosclerosis.